• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 13, 2023

Study: Frequent Use of Antibiotics Shows Link to IBD

Author(s):

Ashley Gallagher, Editor

Analysis indicates that for individuals older than aged 40 years, the risk is cumulative and greatest 1 to 2 years after use.

Frequent use of antibiotics may heighten the risk of inflammatory bowel disease (IBD), including Crohn disease and ulcerative colitis, among individuals aged 40 or older, according to the results of a study published in Gut.

The findings show that the risk is cumulative and greatest 1 to 2 years after use from antibiotics that target gut infections.

Previous evidence has suggested that environmental factors can contribute to the development of IBD, with 1 of the factors associated with younger individuals is the use of antibiotics. However, previously, it was unclear if the associated applied to those who are older.

Investigators used national medical data from 2000 to 2018 for Danish citizens aged 10 years or older who were not diagnosed with IBD. They wanted to determine if dosing and timing of antibiotics were important factors for the development of IBD, as well as if it varied by antibiotic type and IBD.

More than 6.1 million individuals were included in the study, with 5.5 million prescribed at least 1 course of antibiotics between 2000 and 2018.

During that time, there were approximately 16,881 new cases of Crohn disease and 36,017 new cases of ulcerative colitis diagnosed.

Overall, when compared with no antibiotic use, these drugs were associated with a high risk of IBD, regardless of age. However, investigators found that older age was associated with the highest risk.

Individuals aged 10 to 40 years older were 28% more likely to be diagnosed with IBD, while those aged 40 to 60 years were 48% more likely to be diagnosed. Investigators also found that approximately 47% of individuals aged 60 years or older were more likely.

The risks were slightly higher for Crohn disease compared with ulcerative colitis at 40%, 62%, and 51%, respectively. The risk seemed to be cumulative, with each subsequent course of antibiotics adding an additional 11%, 15%, and 14% higher risk, respectively.

The highest risk was observed among those who were prescribed 5 or more courses of antibiotics, with a 69% heightened risk for individuals aged 10 to 40 years, double the risk for those aged 40 to 60 years, and a 95% heightened risk for those aged 60 years and older.

Investigators also determined that timing mattered, with the highest risk of IBD occurring about 1 to 2 years after antibiotic exposure, with each subsequent year associated with a lower risk.

Among those aged 10 to 40 years, the IBD risk was 40% higher at 1 to 2 years after taking antibiotics compared with 13%, 4 to 5 years later. For those aged 40 to 60 years, the risk was 66% and 21%, respectively, and those aged 60 years, 63% and 22%, respectively.

The highest risk of IBD was associated with fluoroquinolones and nitroimidazoles, broad-spectrum antibiotics typically used to treat gut infections. Nitrofurantoin was the only antibiotic type not associated with IBD risk at any age.

Furthermore, narrow-spectrum penicillin was associated with IBD but to a much lesser extent.

The information available did not include what the drugs were for or how many of them patients took, investigators said.

Reference

Frequent use of antibiotics may heighten inflammatory bowel disease risk in over 40s. EurekAlert. News release. January 9, 2023. Accessed January 10, 2023. https://www.eurekalert.org/news-releases/975780

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit:  kitsawet | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Related Content
Advertisement
Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine
July 8th 2025

Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine

Dina Ibrahim, PharmD Candidate 2026
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Pediatric patient with IBD-related pain -- Image credit: Khunatorn | stock.adobe.com
July 8th 2025

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

Gillian McGovern, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Immune marker Assesses globulin levels, elevated in cancers
July 7th 2025

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Luke Halpern, Assistant Editor
Hepatocellular Carcinoma Cells: These liver cells, or hepatocytes, can develop into tumors in the liver, often associated with cirrhosis or chronic liver disease - Image credit: Best | stock.adobe.com
July 7th 2025

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine
July 8th 2025

Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine

Dina Ibrahim, PharmD Candidate 2026
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Pediatric patient with IBD-related pain -- Image credit: Khunatorn | stock.adobe.com
July 8th 2025

Infliximab Biosimilar Initiation Has Increased in Pediatric IBD, Study Finds

Gillian McGovern, Associate Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Immune marker Assesses globulin levels, elevated in cancers
July 7th 2025

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Luke Halpern, Assistant Editor
Hepatocellular Carcinoma Cells: These liver cells, or hepatocytes, can develop into tumors in the liver, often associated with cirrhosis or chronic liver disease - Image credit: Best | stock.adobe.com
July 7th 2025

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.